alone in locally advanced rectal cancer. Appl ID 1048035 Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Production of Priority-driven Off The Shelf T-cells Expressing Collaborative a Non-MHC Restricted CD19 Cancer University of Cancer Specific Chimeric Antigen $47,500 04/03/2013 37 University of Sydney 2006 Australia Sydney Research Receptor for use in a Phase I Scheme Study of T-cell Therapy of Relapsed and Refractory Bcell Malignancies (UNI-T Study). Appl ID 1047454 Priority Driven Collaborative Cancer Research Scheme Priority-driven (PDCCRS) 2012: Investigating Collaborative Cancer University of the mechanism of action of Cancer $24,972.75 04/03/2013 12 University of Sydney 2006 Australia Sydney the cancer-associated Research enzyme telomerase using Scheme disease linked telomerase mutants. Appl ID 1048376 Priority Driven Collaborative Cancer Research Scheme Priority-driven (PDCCRS) 2012: The Collaborative of adjuvant Cancer University of Cancer whole brain radiotherapy for $184,475 04/03/2013 36 University of Sydney 2006 Australia Sydney Research melanoma brain metastases: Scheme a trial-based and modelled economic evaluation. Appl ID 1046923 Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: ICON8: An Priority-driven international multi-stage Collaborative randomised phase III trial of Cancer University of Cancer dose-fractionated $257,241 04/03/2013 36 University of Sydney 2006 Australia Sydney Research chemotherapy compared to Scheme standard three-weekly chemotherapy for women with newly diagnosed epithelial ovarian cancer.
alone in locally advanced rectal cancer. Appl ID 1048035 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Production of Off The Shelf T-cells Expressing a Non-MHC Restricted CD19 Specific Chimeric Antigen Receptor for use in a Phase I Study of T-cell Therapy of Relapsed and Refractory Bcell Malignancies (UNI-T Study). Appl ID 1047454 $47,500 04/03/2013 37 University of Sydney 2006 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Investigating the mechanism of action of the cancer-associated enzyme telomerase using disease linked telomerase mutants. Appl ID 1048376 $24,972.75 04/03/2013 12 University of Sydney 2006 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: The of adjuvant whole brain radiotherapy for melanoma brain metastases: a trial-based and modelled economic evaluation. Appl ID 1046923 $184,475 04/03/2013 36 University of Sydney 2006 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: ICON8: An international multi-stage randomised phase III trial of dose-fractionated chemotherapy compared to standard three-weekly chemotherapy for women with newly diagnosed epithelial ovarian cancer. $257,241 04/03/2013 36 University of Sydney 2006
grants_reporting_20170922.docx